HP Inc. (HPQ) reported a 26% jump in earnings for the third quarter as double-digit growth in the PC and Printer divisions drove revenue higher. The top and bottom lines exceeded analysts’ expectations and the company raised its earnings guidance for the full year.
Earnings surged 26% to $880 million or $0.54 per share. Non-GAAP earnings per share increased 21% to $0.52.
Revenue for the quarter grew 12% to $14.6 billion.
Personal Systems division, which brings in a lion’s share to the company’s top line, continued its strong performance, improving sales by 12% to $9.4 billion. Meanwhile, the printing segment saw 11% growth over last year bringing in $5.2 billion to the top line.
Total hardware units were up 12% with Commercial hardware units showing huge year-over-year growth compared to the slight rise in Consumer hardware units.
Looking ahead, HP expects its earnings to be between $0.48 and $0.51 per share. On an adjusted basis, earnings are expected to be $0.52 to $0.55 per share.
For the fiscal year 2018, HP lifted non-GAAP EPS outlook to the range of $2.00 to $2.03 from prior estimate of $1.97 to $2.02. GAAP earnings are now predicted to be $2.82 to $2.85 for the full year 2018.
The company used $0.2 billion worth of cash for dividend payment of $0.1393 per share in the third quarter. HP utilized $0.7 billion of cash to repurchase about 30.4 million shares of common stock in the open market. As a result, HP returned 66% of its free cash flow to shareholders in the third quarter.
HP exited the third quarter with $7.1 billion in gross cash, which includes cash and cash equivalents and short-term investments of $0.9 billion included in other current assets. HP generated $1.4 billion of free cash flow in the third quarter.
Shares of HP ended Thursday’s regular trading session up 0.49% at $24.63 on the NYSE. The stock turned negative in the after-hours following the results.
Related: HP reports solid 2Q results, appoints new CFO
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on